FEATHER WEIGHT LOSS
Medication Options
At Feather Weight Loss, we offer access to today’s most effective prescription weight-loss medications, including GLP-1 and dual-agonist therapies. These treatments help reduce appetite, improve metabolic function, and support sustainable weight loss when combined with healthy lifestyle habits. Our providers work with you to determine the best option based on your medical history, goals, and insurance or self-pay preferences.
Wegovy (Semaglutide Injection)
Wegovy is an FDA-approved once-weekly injectable medication for chronic weight management. It works by mimicking the GLP-1 hormone to reduce appetite, slow digestion, and increase feelings of fullness, which helps patients naturally eat less. When combined with healthy nutrition and physical activity, many patients experience steady and sustainable weight loss.
Wegovy Daily Pill (Oral Semaglutide)
The Wegovy pill contains the same active ingredient as the injectable form, semaglutide, but is taken once daily instead of weekly. It offers a needle-free alternative for patients who prefer oral medication. The pill must be taken on an empty stomach with water, and you must wait at least 30 minutes before eating, drinking anything else, or taking other medications. When taken consistently, it provides similar appetite-control and weight-loss benefits.
Zepbound (Tirzepatide Injection)
Zepbound is an FDA-approved weekly injectable medication for weight management. It contains tirzepatide, which targets both GLP-1 and GIP receptors, offering stronger appetite suppression and metabolic support. This dual-action therapy has shown some of the highest weight-loss results among current medications.
Compounded Semaglutide Injection
Compounded semaglutide contains the same active ingredient as Wegovy and Ozempic and is available through trusted partner pharmacies for patients whose insurance does not cover brand-name medications. These compounded formulations are customizable and not limited to a strict once-weekly schedule, allowing providers to tailor dosing to individual patient needs while offering a more affordable self-pay option.
Compounded Tirzepatide Injection
Compounded tirzepatide contains the same active ingredient as Zepbound and Mounjaro and is offered as a self-pay alternative when brand-name coverage is unavailable. These formulations are customizable and not restricted to a strict once-weekly schedule, allowing dosing to be adjusted based on patient response and tolerance while maintaining the same dual-hormone mechanism for appetite control and weight loss.
Ozempic and Mounjaro Injections
Ozempic and Mounjaro are weekly injectable medication originally approved for type 2 diabetes and commonly prescribed off-label for weight loss. They works by decreasing hunger, slowing digestion, and improving blood sugar control, often leading to meaningful weight reduction.